VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $15.5 million in its first quarter.
On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 18 cents.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The biotechnology company posted revenue of $30,000 in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $53,000.
Aurinia shares have climbed 16 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.26, a decrease of 28 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH